1. Yeast paves the way for cancer immunotherapy.
- Author
-
Jia D and Chen S
- Subjects
- Humans, Immune Checkpoint Inhibitors therapeutic use, Immune Checkpoint Inhibitors pharmacology, Saccharomyces cerevisiae metabolism, Immunotherapy, Neoplasms therapy, Neoplasms immunology, Neoplasms drug therapy
- Abstract
In this issue of Cell Chemical Biology, Rebeck et al.
1 construct a system that enables Saccharomyces cerevisiae var. boulardii (Sb) to secrete immune checkpoint inhibitors, reducing intestinal tumor load. This safe and effective delivery platform using engineered yeast demonstrates potential for enhancing the efficacy of biologics., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2024 Elsevier Ltd. All rights reserved.)- Published
- 2025
- Full Text
- View/download PDF